Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

US9714235B2 · kind B2 · utility

Assignee

• Shanghai Fochon Pharmaceutical Co., Ltd. · CN

Inventors

• Weibo Wang · Moraga, US
• Xingdong Zhao · Chongqing, CN
• Tongshuang Li · Surrey, CA
• Qiang Tian · Sichuan, CN
• Ling Chen · Shanghai, CN
• Zuwen Zhou · Chongqing, CN
• Zhifu Li · 红钢城街道, CN
• Xianlong Wang · Chongqing, CN
• Yue Rong · Chongqing, CN
• Lihua Jiang · Beijing, CN
• Yanxin Liu · Chongqing, CN
• Jing Sun · Suzhou, CN
• Fanxin Zeng · Chongqing, CN

Key dates

• Filing date: Jul 17, 2014
• Grant date: Jul 25, 2017
• Expiry date: Jul 17, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use thereof.